A genetic test known as chromosomal microarray analysis (CMA) could help identify the cause of sudden infant death syndrome (SIDS) or its counterpart in older children, known as sudden unexplained ...
FRAMINGHAM, Mass.--(BUSINESS WIRE)--Variantyx, a leader in genomic precision medicine, today announced the launch of its IriSight™ CNV Analysis - a whole genome-based test for the detection of ...
March 16, 2010 (Updated March 18, 2010) — Chromosomal microarray analysis (CMA) is at least 3 times more effective at identifying genetic abnormalities in autism spectrum disorder (ASD) than other ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback